Prolonged social withdrawal (“hikikomori”) and its associations with depressive symptoms and suicidal ideation among young adults in Korea: Findings from the 2022 Youth Life Survey
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.04.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Seong-Uk Baek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Suicidal Ideation, Depression, Social Isolation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; The Institute for Occupational Health, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic addr…
Zitieren
APA
Baek, S. U., & Yoon, J. H. (2025). Prolonged social withdrawal (“hikikomori”) and its associations with depressive symptoms and suicidal ideation among young adults in Korea: Findings from the 2022 Youth Life Survey. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.04.044
Vancouver
Baek SU, Yoon JH. Prolonged social withdrawal (“hikikomori”) and its associations with depressive symptoms and suicidal ideation among young adults in Korea: Findings from the 2022 Youth Life Survey. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.04.044
BibTeX
@article{Baek2025,
author = {Baek, Seong-Uk and Yoon, Jin-Ha},
title = {Prolonged social withdrawal (“hikikomori”) and its associations with depressive symptoms and suicidal ideation among young adults in Korea: Findings from the 2022 Youth Life Survey},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.04.044}
}
EUVIMED